Walker Neal (CIK 0001604457)

Latest company ownership

Shares held
9,467
Last filed at
May 5, 2025
Confidence Score
50.3
2025Q4
Confidence Score History
2016Q4 2025Q4
Shares held
1,736
Last filed at
Jun 6, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2014Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 1, 2025 May 5, 2025 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,975 -0.20% ✗ $4.1K
Apr 1, 2025 Apr 3, 2025 Aclaris Therapeutics, Inc. CEO Sell 52.5 -3,042 -0.21% ✗ $4.5K
Mar 1, 2025 Mar 4, 2025 Aclaris Therapeutics, Inc. CEO Sell 52.5 -3,277 -0.22% ✗ $6.5K
Feb 1, 2025 Feb 4, 2025 Aclaris Therapeutics, Inc. CEO Sell 52.5 -3,559 -0.24% ✗ $8.8K
Jan 1, 2025 Jan 3, 2025 Aclaris Therapeutics, Inc. CEO Sell 48.8 -17,436 -0.60% ✗ $43.2K
Dec 4, 2024 Dec 6, 2024 Aclaris Therapeutics, Inc. CEO Sell 40.0 -68,343 -4.55% ✗ $257K
Dec 1, 2024 Dec 3, 2024 Aclaris Therapeutics, Inc. CEO Sell 51.3 -2,721 -0.20% ✗ $11.1K
Nov 1, 2024 Nov 5, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,721 -0.20% ✗ $5.7K
Oct 1, 2024 Oct 3, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,722 -0.20% ✗ $3.2K
Sep 1, 2024 Sep 4, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,722 -0.20% ✗ $3.2K
Aug 1, 2024 Aug 5, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,722 -0.21% ✗ $3.6K
Jul 1, 2024 Jul 3, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,722 -0.21% ✗ $3.1K
Jun 1, 2024 Jun 4, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,722 -0.21% ✗ $2.8K
May 1, 2024 May 3, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -2,784 -0.21% ✗ $3.5K
Apr 1, 2024 Apr 3, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -3,224 -0.25% ✗ $4.1K
Mar 1, 2024 Mar 5, 2024 Aclaris Therapeutics, Inc. CEO Sell 52.5 -3,223 -0.25% ✗ $4K
Mar 1, 2023 Mar 3, 2023 Aclaris Therapeutics, Inc. Director Sell 40.0 -59,240 -2.26% ✗ $740.7K
Feb 1, 2023 Feb 3, 2023 Aclaris Therapeutics, Inc. Director Sell 38.8 -30,000 -2.49% ✓ $499.9K
Jan 3, 2023 Jan 4, 2023 Aclaris Therapeutics, Inc. Director Sell 35.0 -40,000 -3.21% ✓ $604.6K
Apr 21, 2022 Apr 25, 2022 Aclaris Therapeutics, Inc. CEO Sell 27.5 -70,000 -5.32% ✓ $1.1M
Mar 11, 2022 Mar 14, 2022 Aclaris Therapeutics, Inc. CEO Sell 40.0 -56,303 -4.10% ✗ $896K
Feb 9, 2022 Feb 11, 2022 Aclaris Therapeutics, Inc. CEO Sell 51.3 -3,595 -0.29% ✗ $45.5K
Jun 1, 2021 Jun 2, 2021 Aclaris Therapeutics, Inc. CEO Sell 40.0 -33,260 -2.63% ✗ $719.7K
Apr 22, 2021 Apr 26, 2021 Aclaris Therapeutics, Inc. CEO Sell 38.8 -30,000 -2.45% ✓ $805.2K
Mar 1, 2021 Mar 3, 2021 Aclaris Therapeutics, Inc. CEO Sell 37.5 -47,774 -1.92% ✗ $1.1M
Feb 1, 2021 Feb 3, 2021 Aclaris Therapeutics, Inc. CEO Sell 47.5 -3,316 -0.29% ✗ $70.8K
Dec 15, 2020 Dec 17, 2020 Aclaris Therapeutics, Inc. CEO Sell 52.5 -871 -0.08% ✗ $4K
Sep 1, 2020 Sep 3, 2020 Aclaris Therapeutics, Inc. CEO Sell 42.5 -23,872 -2.04% ✗ $55.6K
Jun 1, 2020 Jun 3, 2020 Aclaris Therapeutics, Inc. CEO Sell 46.3 -20,976 -1.89% ✗ $27.7K
Mar 2, 2020 Mar 4, 2020 Aclaris Therapeutics, Inc. CEO Sell 42.5 -42,724 -2.06% ✗ $53.8K
Feb 3, 2020 Feb 4, 2020 Aclaris Therapeutics, Inc. CEO Sell 52.5 -3,675 -0.39% ✗ $4.7K
Dec 18, 2019 Dec 20, 2019 Aclaris Therapeutics, Inc. CEO Sell 52.5 -743 -0.08% ✗ $1.3K
Dec 16, 2019 Dec 18, 2019 Aclaris Therapeutics, Inc. CEO Sell 52.5 -782 -0.08% ✗ $1.4K
Feb 1, 2019 Feb 5, 2019 Aclaris Therapeutics, Inc. CEO Sell 51.3 -3,579 -0.39% ✗ $24.9K
Dec 18, 2018 Dec 21, 2018 Aclaris Therapeutics, Inc. CEO Sell 52.5 -833 -0.09% ✗ $5.2K
Dec 15, 2018 Dec 18, 2018 Aclaris Therapeutics, Inc. CEO Sell 52.5 -863 -0.09% ✗ $6.3K
May 7, 2018 May 9, 2018 Aclaris Therapeutics, Inc. CEO Sell 47.5 -3,455 -0.38% ✗ $62.5K
Apr 5, 2018 Apr 9, 2018 Aclaris Therapeutics, Inc. CEO Buy 82.5 +10,000 1.13% ✓ $167.5K
Dec 15, 2017 Dec 21, 2017 Aclaris Therapeutics, Inc. CEO Sell 51.3 -1,811 -0.10% ✗ $43.8K
Dec 18, 2016 Dec 20, 2016 Aclaris Therapeutics, Inc. CEO Sell 51.3 -889 -0.10% ✗ $27.8K
May 7, 2014 May 8, 2014 Aldeyra Therapeutics, Inc. Director Buy 95.0 +6,250 100.00% ✗ $50K